share_log

Cantor Fitzgerald Initiates Coverage On KemPharm With Overweight Rating, Announces Price Target of $20

Benzinga Real-time News ·  Nov 17, 2022 06:22

Cantor Fitzgerald analyst Louis Chen initiates coverage on KemPharm (NASDAQ:KMPH) with a Overweight rating and announces Price Target of $20.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment